Introduction
============

The hematological features of visceral leishmaniasis (VL) have evoked particular interest because of their high frequency and severity and because they cause significant mortality and morbidity.[@b1-mjhid-9-1-e2017056],[@b2-mjhid-9-1-e2017056],[@b3-mjhid-9-1-e2017056] There are frequent reports of the hematological manifestations which describe mainly their relative frequencies in different regions of the world.[@b3-mjhid-9-1-e2017056],[@b4-mjhid-9-1-e2017056] Common non-specific hematological features of VL include anemia, leukopenia, thrombocytopenia, and pancytopenia.[@b3-mjhid-9-1-e2017056],[@b5-mjhid-9-1-e2017056],[@b6-mjhid-9-1-e2017056] Such hematological features are also frequently encountered in patients with hematological malignancies such as acute leukemia, lymphomas, and myelodysplastic syndrome as well as various infectious diseases.[@b7-mjhid-9-1-e2017056] There are also frequent reports of VL presenting as an autoimmune disease mimicking autoimmune hepatitis, primary biliary cirrhosis, rheumatoid arthritis and systemic lupus erythematosus.[@b8-mjhid-9-1-e2017056],[@b9-mjhid-9-1-e2017056] Higher rates of morbidity and mortality are consequences of the delay in diagnosis.[@b10-mjhid-9-1-e2017056],[@b11-mjhid-9-1-e2017056],[@b12-mjhid-9-1-e2017056] VL is also reported to be one of the most common causes of fever of unknown origin causing troublesome diagnosis in a European low-income country.[@b13-mjhid-9-1-e2017056] In addition to the non-specificity of clinical and general laboratory features of VL, the confirmatory laboratory tests with the exception of identification of the parasites in Giemsa stained tissue aspirates, are usually interpreted in the light of clinical and epidemiological data which are not helpful in non-endemic areas.[@b14-mjhid-9-1-e2017056],[@b15-mjhid-9-1-e2017056] On the other hand, the sensitivity of bone marrow aspirates, which is comparatively a safer procedure compared to splenic aspirates for identification of the parasite, was found to be proportional to the amount of time spent searching for the amastigotes ( 65.5 percent and 95.4 percent at 5 minutes and one hour respectively).[@b16-mjhid-9-1-e2017056] Finding a collection of hematological features will help to demand a diligent search to confirm the diagnosis particularly in non-endemic areas. Only a few reports have looked at hematological manifestations as helpful clues for the diagnosis, which included mainly bone marrow cytological features.[@b17-mjhid-9-1-e2017056],[@b18-mjhid-9-1-e2017056] In Yemen, Leishmania IgG ELISA is rarely available in some centres and experience showed it to be unreliable because of the high frequency of false positive and false negative results when compared to identification of the parasites in Giemsa stained tissue aspirates. Such findings were also addressed by WHO expert group who reported that a significant proportion of people living in endemic areas with no history of VL is positive for antileishmanial antibodies owing to asymptomatic infections.[@b15-mjhid-9-1-e2017056] The experts also recommend that in areas of low endemicity more accurate diagnostic algorithms are required that would include parasitology in blood and bone marrow. The role of serology in the diagnosis of VL has been reviewed.[@b19-mjhid-9-1-e2017056],[@b20-mjhid-9-1-e2017056] PCR for the diagnosis of leishmania is not available in Yemen, and only one report has been recently published in which PCR was used for research purposes with the collaboration of University of Malaya and reported the first Molecular characterization of VL in Yemen.[@b21-mjhid-9-1-e2017056] Therefore, identification of the parasites in Giemsa stained bone marrow aspirate smears remains the only reliable diagnostic method for the diagnosis of VL in Yemen.[@b3-mjhid-9-1-e2017056],[@b22-mjhid-9-1-e2017056] In our experience, we observed that in addition to known hematological features, the presence of marked bone marrow eosinopenia constitutes a crucial clue to the presence of visceral leishmaniasis in challenging cases. Such evidence prompted a careful review of the smears searching for amastigotes, which were identified -although sometimes with a little and scanty distribution- in all suspected cases showing these two features. The aim of this study is to evaluate systematically the hematological characteristics of Yemeni adults and children with VL including objective documentation of the frequency and degree peripheral and bone marrow eosinopenia to find clues that may help to arrive at the diagnosis early. This procedure by avoiding delay in specific treatment will decrease morbidity and mortality. A full epidemiological study of VL in Yemen is not available. The causative organisms are Leishmania donovani complex (anthroponotic VL) and Leishmania infantum complex (zoonotic VL). The pattern of VL in Yemen derives from the few studies published. The disease seems to be endemic in the country, particularly in Hajjah, Taiz and Amran governorates of the Northern part of the country and Lahj and Abyan governorates of the south of the country.[@b3-mjhid-9-1-e2017056],[@b22-mjhid-9-1-e2017056]

Materials and Methods
=====================

The study is a descriptive analytic study conducted in Sana'a, which is the capital city of Yemen, at the hematology unit of Al-Jomhori teaching hospital which is a referral tertiary teaching hospital. The hematology unit deals with all types of hematological diseases including hematological malignancies which are referred from all over the country. The study included 47 patients with VL who were prospectively evaluated and managed at our center between October 2010 and October 2014. Their diagnosis was confirmed by identification of amastigotes in Giemsa stained bone marrow smears. Complete blood count (CBC) was done for each patient using an automated cell counter (Sysmex Automated machine, Sysmex Corporation, Kobe, Japan), The white blood cell count (WBC) differential and red blood cell (RBC) morphology were confirmed manually by a well-trained laboratory hematologist and adjusted accordingly. One peripheral blood Giemsa stained smear and three bone marrow aspiration Giemsa stained smears were examined by the consultant laboratory and clinical hematologist. Informed consent was obtained from the patients or responsible persons and the study was approved by the Ethical Committee of the Faculty of Medicine and Health Sciences of Sana'a University.

The control group included 51 subjects, randomly selected from the records of 207 non-VL patients, 60 years old or younger (considering that the maximum age for patients with VL was 60 years old), who presented with fever, splenomegaly and pancytopenia or bicytopenia during the period of the study between October 2010 and October 2014. Their presenting CBC and WBC differential were taken before any treatment. They were performed by the same machine and in the same way as for all patients including patients with VL. The bone marrow examination was carried out at initial presentation as part of the evaluation of their splenomegaly and cytopenia. Their marrow aspiration Giemsa stained smears were reviewed to determine the eosinophil series percentage and to compare the results with those of patients with VL. They were examined by the same laboratory and clinical hematologist who reviewed the bone marrow smears of patients with VL.

Definitions
-----------

Bone marrow eosinopenia: eosinophil series count of less than 0.3% of total marrow myeloid cells calculated as the average number in at least 20 cellular fields examined i.e. at least 20×200= 4000 cells were counted \[Normal range of eosinophils on aspirated bone marrow: 0.3--4.0% and the normal mean: 2.2%\].[@b23-mjhid-9-1-e2017056]

### Dyserythropoiesis

Presence of dysplastic changes of erythropoiesis including megaloblastic features, binuclear and polynuclear normoblasts and other dyserythropoietic features (e.g. internuclear bridges, nuclear budding) with a frequency of \> 5 per 100 erythroid cells

### Hypercellular marrow

A cellularity \> 50% in adults and \> 80% in children.

### Increased lymphocytes (marrow)

Lymphocytes \> 5% of total non-erythroid cells in adults and \> 10% in children.

### Increased plasma cells (marrow)

Plasma cells \> 5% of total non-erythroid cells in both adults and children.

### Hemophagocytosis

Presence in the bone marrow of macrophages which phagocytize blood and bone marrow cells including red cells, erythroblasts, other leukocytes and or platelets.

### Evaluation of iron stores

Decreased marrow iron stores: less than one iron-positive cell, on the average for each × 40 field or absent iron-positive cells; increased marrow iron stores: more than two iron-positive cell for each × 40 field. Decreased marrow sideroblasts: sideroblasts less than 3% of total erythroblasts in the marrow.[@b24-mjhid-9-1-e2017056]

Statistical analysis
--------------------

The data were collected, tabulated and compiled in a computer database. SPSS version 21 was used to analyze data. Frequencies and percentages were used to describe categorical data. Unpaired Independent Samples T test was used to evaluate the comparison between adults and children regarding the means of Hb, PCV, MCV, MCH, WBC, platelet, neutrophil, lymphocyte, monocyte and eosinophil counts. Chi squared test was used to compare the degree of abnormal peripheral blood counts and also the peripheral blood and bone marrow morphological data between adults and children. Unpaired Independent Samples T test was used to evaluate the comparison between Patients with VL and control subjects regarding the means of Hb, WBC, platelet, neutrophil, lymphocyte, monocyte, and eosinophil counts. Chi squared test was used to compare the degree of abnormal peripheral blood counts and bone marrow eosinopenia between VL patients and controls.

Results
=======

Forty-seven (32 males and 15 females) patients with the main age (±SD) of 17.34±11.37 years (Range: 1--60) were included in the study. Of these patients, 28 (59.6%) were adults aged 16--60 years with a mean age (±SD) of 24.3 years ±9.2 and 19 (40.4%) patients were children aged 1--15 years with a mean age (±SD) of 7.1 years ±4.7.

[Table 1](#t1-mjhid-9-1-e2017056){ref-type="table"} shows the mean values of the peripheral blood counts of adults and children with VL and [table 2](#t2-mjhid-9-1-e2017056){ref-type="table"} shows the type and degree of abnormal peripheral blood counts.

All patients had moderate to severe anemia (Hb range: 4.6--10.4 g/dl) including 16 (32%) patients who had severe anemia; only one patient had Hb \> 10 g/dl (10.4 g/dl).

Forty-one (87%) patients had leukopenia, and 42 (89.4%) patients had neutropenia including 34 (72.3%) patients who had significant neutropenia.

Thrombocytopenia was present in 44 (93.6%) patients including 39 (83%) patients who had significant thrombocytopenia. Eosinopenia was present in 42 (89.4%) patients including 27 (57.4%) patients who had absolute eosinopenia.

All patients had either pancytopenia or bicytopenia: 34 (72.3%) and 13 (27.7%) respectively).

The red blood cell morphological characteristics of Yemeni adults and children with visceral leishmaniasis showed that anisocytosis, anisochromia, and microcytic RBCs were the most common red blood cell morphological findings which were present in 30 (63.8%), 25 (53.2%) and 23 (49%) respectively. Ten (21%) patients had poikilocytosis, and five (10%) had tear drop red blood cells.

[Table 3](#t3-mjhid-9-1-e2017056){ref-type="table"} shows the bone marrow morphological characteristics of Yemeni adults and children with visceral leishmaniasis. Regarding bone marrow morphological findings, marked bone marrow eosinopenia was the most common finding which was seen in 44 (93.6%) patients. Forty (85%) patients had hypercellular marrow, and 24 (51%) patients had dyserythropoiesis. Decreased iron stores were present in 27 (57.4%) patients, and 20 (42.6%) had a reduced number of sideroblasts. Only three (6.4 %) patients had increased iron stores. Hemophagocytosis was recognized in two (4.3) patients, and bone marrow plasmacytosis was seen in eight (17%) patients ([Figures 1](#f1-mjhid-9-1-e2017056){ref-type="fig"},[2](#f2-mjhid-9-1-e2017056){ref-type="fig"},[3](#f3-mjhid-9-1-e2017056){ref-type="fig"}).

The control group included 51 subjects (30 males and 21 females) with the main age (±SD) of 20.71±11.92 years (Range: 0.5--60). The mean values of the peripheral blood counts of control subjects was 7.80±1.75 (g/dl) for Hb, 2703.92±826.55 (×10^6^/L) for WBC, 1069.76±626.50 (×10^6^/L) for neutrophils, 1347.76±630.26 (×10^6^/L) for lymphocytes, 88.10±108.84 (×10^6^/L) for eosinophils, 201.06±197.72 (×10^6^/L) for monocytes and 74.65±62.68 (×10^9^/L) for platelets. Comparison of the mean values of peripheral blood counts between patients with VL and control subjects showed no significant difference in any of the above mean values except that patients had significantly lower eosinophil counts (p value 0.000) and lower lymphocyte count (p value 0.014). [Table 4](#t4-mjhid-9-1-e2017056){ref-type="table"} shows comparison of abnormal peripheral blood counts and bone marrow eosinopenia between Yemeni patients with VL and control subjects. Patients had significantly more peripheral blood eosinopenia and lymphopenia and bone marrow eosinopenia compared to control subjects.

Discussion
==========

Our study showed that anemia, leukopenia, neutropenia, thrombocytopenia, eosinopenia, and pancytopenia were the most common peripheral blood findings in patients with VL and that hypercellularity, eosinopenia, dyserythropoiesis, lymphocytosis and decreased marrow iron were the most common bone marrow findings.

Most hematological features including anemia, leukopenia, thrombocytopenia, and pancytopenia are non-specific. Such features are frequent in patients with other infectious diseases, some hematological disorders and some autoimmune collagenous diseases (7,25--28). Diagnosis of VL is straight forward in endemic areas where the disease is suspected and aided by confirmatory laboratory tests including reliable serological tests.[@b14-mjhid-9-1-e2017056] However, in non-endemic areas, the differential diagnosis includes a broad spectrum of diseases as mentioned above and serological diagnosis is not reliable.[@b15-mjhid-9-1-e2017056] Finding amastigotes in tissue smears is the most reliable diagnostic test. Splenic aspiration is a risky procedure and is not a usual in non-endemic areas. Bone marrow aspiration remains the safest procedure. However, the sensitivity of such method depends on the time spent examining the smears.[@b16-mjhid-9-1-e2017056] Paying careful oriented attention and adequate time searching for the parasites increases the sensitivity to around 100%. However, such a time which may take few hours cannot be paid for all patients presenting with the above hematological features because of the high incidence of the diseases presenting with such features. Finding additional clues may limit the number of cases highly suspected of being VL, which need careful, time-consuming study.

The peripheral blood features of our patients which included anemia, thrombocytopenia, leukopenia, bicytopenia, and pancytopenia are not different from those reported from other studies in Asia, Africa, and Mediterranean region or South America.[@b4-mjhid-9-1-e2017056],[@b29-mjhid-9-1-e2017056] Hypercellular marrow and dyserythropoiesis were also common in our patient group which is similar to that reported in other studies.[@b30-mjhid-9-1-e2017056],[@b31-mjhid-9-1-e2017056] Bone marrow lymphocytosis was also frequent among our patients similar to other studies.[@b6-mjhid-9-1-e2017056] Our patients also had significant peripheral blood lymphocytopenia. The presence of peripheral blood lymphopenia in association with bone marrow lymphocytosis has been explained by the notion that lymphocytes migrate to the affected lymphoid tissues to build an inflammatory response and that bone marrow lymphocytosis is a compensatory response that provides lymphocytes to organs affected by the parasite.[@b32-mjhid-9-1-e2017056],[@b33-mjhid-9-1-e2017056] Only one child and one adult of our patients had bone marrow features of hemophagocytosis. Hemophagocytosis was reported to be a rare occurrence in patients with visceral leishmaniasis causing diagnostic dilemma and unusual presentation.[@b11-mjhid-9-1-e2017056],[@b34-mjhid-9-1-e2017056] Our patients showed decreased marrow iron which is consistent with their common finding of microcytic red blood cells. This picture is due to the malnutrition these patients usually have as a consequence of anorexia and is also explained by the fact that the disease affects the poor population predominantly.[@b25-mjhid-9-1-e2017056],[@b35-mjhid-9-1-e2017056] Severe anemia, malnutrition and long duration of illness were shown to be associated with an increased risk of death.[@b25-mjhid-9-1-e2017056],[@b36-mjhid-9-1-e2017056] These issues should be addressed in evaluating and managing patients with VL. The marked bone marrow eosinopenia associated with marked peripheral blood eosinopenia are the characteristics which were most common in our patients with VL and usually are not reported both together in other simulating illnesses. Bone marrow eosinopenia in VL has not been signaled in humans so far. However, it has been reported in symptomatic canine VL as opposed to asymptomatic canine VL and was found to be correlated with peripheral eosinopenia and it has been regarded together with peripheral blood lymphocytopenia as a biomarker of severe disease.[@b37-mjhid-9-1-e2017056] Eosinophilic hypoplasia in symptomatic canine VL has been explained by bone marrow dysfunction, which may have contributed to the severe eosinopenia.[@b37-mjhid-9-1-e2017056],[@b38-mjhid-9-1-e2017056] On the other hand, Eosinophil infiltration in the lymph-nodes of mice infected by Leishmania major was found to be influenced by sex and parasitic load and that it reflects ineffective inflammation.[@b39-mjhid-9-1-e2017056] The previous studies in humans on hematological manifestations of VL did not evaluate bone marrow eosinopenia as a feature or as a clue to the diagnosis of the disease. A single study reported three of 18 bone marrow aspirates who had prominent marrow eosinophils.[@b40-mjhid-9-1-e2017056] However, the authors themselves of the study did not find any report of similar observation in the searched medical literature. We also didn't find other reports of this finding of marrow eosinophilia. Therefore, secondary causes of eosinophilia could not be excluded in these cases. Furthermore, the percentage of those patients with eosinophilia was too small to regard it a significant finding: 3/18 \[16%\].[@b40-mjhid-9-1-e2017056] Our study also showed that there was no significant difference between adults and children regarding peripheral blood and bone marrow eosinopenia or concerning other hematological features.

Conclusions
===========

Based on the above findings we conclude that in the proper clinical setting associated with peripheral blood cytopenias, the finding of marked bone marrow eosinopenia is a critical clue for the diagnosis of symptomatic VL demanding careful, lengthy search for the parasites in bone marrow aspirate smears. This finding is particularly valuable in non-endemic areas.
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###### 

The mean values of peripheral blood counts of Yemeni adults and children and with *visceral leishmaniasis.*

  Parameter              All patients\*    Children\* (no=19)   Adults\* (no=28)   P value
  ---------------------- ----------------- -------------------- ------------------ ---------
  Hb (g/dl)              7.49±1.37         7.04±1.39            7.83±1.30          0.057
  PCV (%)                24.47±4.07        24.14±4.43           24.96±4.06         0.572
  MCV (fl)               75.2±6.16         71.44±4.95           77.95±5.19         0.004
  MCH (pg)               23.74±2.31        22.07±2.58           24.62±1.1.92       0.006
  Reticulocyte (%)       1.57±1.13         1.75±1.32            1.41±0.93          0.465
  WBC × 10^6^/L          2097.87±1304.59   2194.74±1089.58      1833.78±937.4530   0.236
  Neutrophil × 10^6^/L   912.02±999.95     607.22±1089.58       995.61±778.70      0.06
  Lymphocyte × 10^6^/L   992.67±773.71     1419.06±852.66       605.87±261.69      \<0.001
  Eosinophil × 10^6^/L   14.19±22.20       13.28±18.34          13.74±25.00        0.948
  Monocyte × 10^6^/L     168.14±147.45     152.78±121.82        171.43±164.36      0.690
  Platelet × 10^9^/L     68.53±45.34       59.32±45.29          77.52±43.86        0.178

###### 

Type and degree of abnormal peripheral blood counts in Yemeni adults and children with visceral leishmaniasis.

  Variable                       All patients (no=47)   Children (no=19)   Adults (no=28)   p value
  ------------------------------ ---------------------- ------------------ ---------------- ---------
  Eosinopenia (\<40 × 10^6^/L)   42 (89.4%)             17 (89.5%)         25 (89.3%)       0.950
  Absolute eosinopenia (0)       27 (57.4%)             11 (57.9%)         16 (57.1%)       0.680
  Hb \<10 (g/dl)                 46 (97.9%)             18 (94.7%)         28 (100%)        0.228
  Hb \<7.0 (g/dl)                16 (31.9%)             8 (42%)            7 (25%)          0.249
  WBC\<3.0 × 10^9^/L             41 (87.2%)             16 (84.2%)         25 (89.3%)       0.368
  Pancytopenia                   34 (72.3%)             14 (73.7%)         20 (71.4%)       0.976
  Bicytopenia                    13 (27.7%)             5 (26.3%)          8 (28.6%)        0.976
  Platelets \<100.0 × 10^9^/L    39(83%)                18 (94.7%)         21 (75%)         0.115
  Platelets \<150.0 × 10^9^/L    44 (93.6%)             18 (94.7%)         26 (92.9%)       0.798
  Neutrophil \< 1.5 × 10^9^/L    42 (89.4%)             19(100%)           23 (82%)         0.063
  Neutrophil \< 1.0 × 10^9^/L    34 (72.3%)             16 (84.2%)         18 (64.3%)       0.194

###### 

Bone marrow morphological characteristics of Yemeni adults and children with *visceral leishmaniasis.*

  Variable                 All patients (no=47)   Children (no=19)   Adults (no=28)   p value
  ------------------------ ---------------------- ------------------ ---------------- ---------
  Hypercellular marrow     40 (85.1%)             16(84%)            24(85.7%)        0.643
  Decreased iron stores    27 (57.4%)             8(47%)             19 (67.9%)       0.335
  Increased iron stores    3 (6.4%)               1 (5.3%)           2 (7.1%)         0.785
  Dyserythropoiesis        24 (51.1%)             11(57.9%)          13 (46.4)        0.369
  Decreased sideroblasts   20 (42.6%)             8 (42%)            12 (42.8%)       0.785
  BM eosinopenia           44 (93.6%)             19 (100%)          25 (89.3%)       0.214
  BM lymphocytosis         22 (46.8%)             8 (42%)            14 (50%)         0.795
  Plasmacytosis            8 (17%)                3 (15.8%)          5 (17.9%)        0.853
  hemophagocytosis         2 (4.3%)               1 (5.3%)           1 (3.6%)         0.778

###### 

Comparison of abnormal peripheral blood counts and bone marrow eosinopenia between Yemeni patients with *visceral leishmaniasis* and control subjects.

  Variable                       patients (no=47)   Control (no=51)   p value
  ------------------------------ ------------------ ----------------- ---------
  Anemia                         47                 51                
  Eosinopenia (\<40 × 10^6^/L)   42 (89.4%)         19 (56.9%)        0.001
  WBC\<3.0 × 10^9^/L             41 (87.2%)         44 (86.3%)        0.889
  Platelets \<100.0 × 10^9^/L    39(83%)            35 (68.6%)        0.099
  Platelets \<150.0 × 10^9^/L    44 (93.6%)         46 (90.2%)        0.825
  Neutrophil \< 1.5 × 10^9^/L    42 (89.4%)         40 (78.4%)        0.767
  Neutrophil \< 1.0 × 10^9^/L    34 (72.3%)         28 (54.9%)        0.369
  Lymphocyte \< 1.0 × 10^9^/L    25 (53.2%)         13 (25.5%)        0.005
  Monocyte \< 0.2 × 10^9^        29 (61.7%)         33 (64.7%)        0.758
  Bone marrow eosinopenia        44 (93.6%)         10 (19.6%)        0.000
